Investors
Analyst Estimates
Shareholder Briefcase
E-mail Alerts
Download Library
REGN Snapshot
RSS News FeedsTarget Price Summary
Current Trading Price: $ 249.04
| Mean: | $ 287.92 |
| Median: | $ 286.00 |
| High: | $ 316.00 |
| Low: | $ 225.00 |
* 17 analysts reported target price for Regeneron Pharmaceuticals, Inc.
Analyst Estimates
| Earnings Per Share |
Current Quarter
Jun 2013 |
Next Quarter
Sep 2013 |
Current Year
Dec 2013 |
Next Year
Dec 2014 |
|---|---|---|---|---|
| Consensus | $ 0.86 | $ 1.00 | $ 3.98 | $ 5.91 |
| High | $ 1.11 | $ 1.50 | $ 7.42 | $ 7.22 |
| Low | $ 0.64 | $ 0.83 | $ 2.59 | $ 3.07 |
| P/E | N/A | N/A | 62.54 | 42.06 |
| Year Ago EPS | $ 0.70 | $ 1.72 | $ 6.75 | $ 3.98 |
| Number of Analyst(s) | 14 | 13 | 15 | 15 |
| Revision(s) Up Last 30 Days |
6 | 7 | 8 | 9 |
| Revision(s) Down Last 30 Days |
7 | 5 | 5 | 3 |
Estimate Analysis
Disclaimer: Average earnings estimates are calculated by FactSet based on their earnings projections made by the analysts who cover Regeneron Pharmaceuticals, Inc. Please note that any opinions, estimates or forecasts regarding Regeneron Pharmaceuticals, Inc.'s performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Regeneron Pharmaceuticals, Inc. or its management. Regeneron Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
